Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ruud A Bank

Showing results (81-90 of 91) with videos related to

Pageof 10
Sort By:
Proceedings of the National Academy of Sciences of the United States of America|January 19, 2010
Distinct defects in collagen microarchitecture underlie vessel-wall failure in advanced abdominal aneurysms and aneurysms in Marfan syndromeJan H N Lindeman, Brian A Ashcroft, Jan-Willem M Beenakker, et al.
Matrix Biology : Journal of the International Society for Matrix Biology|August 7, 2004
Increased formation of pyridinoline cross-links due to higher telopeptide lysyl hydroxylase levels is a general fibrotic phenomenonAnnemarie J van der Slot, Anne-Marie Zuurmond, Antoon J van den Bogaerdt, et al.
American Journal of Physiology. Renal Physiology|November 19, 2019
Inhibition of tyrosine kinase receptor signaling attenuates fibrogenesis in an ex vivo model of human renal fibrosisEmilia Bigaeva, Elisabeth G D Stribos, Henricus A M Mutsaers, et al.
Arthritis and Rheumatism|April 13, 2004
Accumulation of advanced glycation end products as a molecular mechanism for aging as a risk factor in osteoarthritisJeroen DeGroot, Nicole Verzijl, Marion J G Wenting-van Wijk, et al.
Arthritis and Rheumatism|February 2, 2002
Crosslinking by advanced glycation end products increases the stiffness of the collagen network in human articular cartilage: a possible mechanism through which age is a risk factor for osteoarthritisNicole Verzijl, Jeroen DeGroot, Zaken Chaya Ben, et al.
The Journal of Biological Chemistry|July 26, 2003
Identification of PLOD2 as telopeptide lysyl hydroxylase, an important enzyme in fibrosisAnnemarie J van der Slot, Anne-Marie Zuurmond, Alfons F J Bardoel, et al.
Pharmaceutics|May 24, 2020
Predictive Value of Precision-Cut Kidney Slices as an Ex Vivo Screening Platform for Therapeutics in Human Renal FibrosisEmilia Bigaeva, Nataly Puerta Cavanzo, Elisabeth G D Stribos, et al.
Circulation. Heart Failure|December 12, 2012
Genetic and pharmacological inhibition of galectin-3 prevents cardiac remodeling by interfering with myocardial fibrogenesisLili Yu, Willem P T Ruifrok, Maxi Meissner, et al.
Biomaterials|February 23, 2010
Intra-uterine tissue engineering of full-thickness skin defects in a fetal sheep modelNynke A Hosper, Alex J Eggink, Luc A J Roelofs, et al.
Human Molecular Genetics|September 6, 2012
Mutations in FKBP10, which result in Bruck syndrome and recessive forms of osteogenesis imperfecta, inhibit the hydroxylation of telopeptide lysines in bone collagenUlrike Schwarze, Tim Cundy, Shawna M Pyott, et al.
Pageof 10

Showing results (81-90 of 91) with videos related to

Sort By:
Pageof 10
Proceedings of the National Academy of Sciences of the United States of America|January 19, 2010
Distinct defects in collagen microarchitecture underlie vessel-wall failure in advanced abdominal aneurysms and aneurysms in Marfan syndromeJan H N Lindeman, Brian A Ashcroft, Jan-Willem M Beenakker, et al.
Matrix Biology : Journal of the International Society for Matrix Biology|August 7, 2004
Increased formation of pyridinoline cross-links due to higher telopeptide lysyl hydroxylase levels is a general fibrotic phenomenonAnnemarie J van der Slot, Anne-Marie Zuurmond, Antoon J van den Bogaerdt, et al.
American Journal of Physiology. Renal Physiology|November 19, 2019
Inhibition of tyrosine kinase receptor signaling attenuates fibrogenesis in an ex vivo model of human renal fibrosisEmilia Bigaeva, Elisabeth G D Stribos, Henricus A M Mutsaers, et al.
Arthritis and Rheumatism|April 13, 2004
Accumulation of advanced glycation end products as a molecular mechanism for aging as a risk factor in osteoarthritisJeroen DeGroot, Nicole Verzijl, Marion J G Wenting-van Wijk, et al.
Arthritis and Rheumatism|February 2, 2002
Crosslinking by advanced glycation end products increases the stiffness of the collagen network in human articular cartilage: a possible mechanism through which age is a risk factor for osteoarthritisNicole Verzijl, Jeroen DeGroot, Zaken Chaya Ben, et al.
The Journal of Biological Chemistry|July 26, 2003
Identification of PLOD2 as telopeptide lysyl hydroxylase, an important enzyme in fibrosisAnnemarie J van der Slot, Anne-Marie Zuurmond, Alfons F J Bardoel, et al.
Pharmaceutics|May 24, 2020
Predictive Value of Precision-Cut Kidney Slices as an Ex Vivo Screening Platform for Therapeutics in Human Renal FibrosisEmilia Bigaeva, Nataly Puerta Cavanzo, Elisabeth G D Stribos, et al.
Circulation. Heart Failure|December 12, 2012
Genetic and pharmacological inhibition of galectin-3 prevents cardiac remodeling by interfering with myocardial fibrogenesisLili Yu, Willem P T Ruifrok, Maxi Meissner, et al.
Biomaterials|February 23, 2010
Intra-uterine tissue engineering of full-thickness skin defects in a fetal sheep modelNynke A Hosper, Alex J Eggink, Luc A J Roelofs, et al.
Human Molecular Genetics|September 6, 2012
Mutations in FKBP10, which result in Bruck syndrome and recessive forms of osteogenesis imperfecta, inhibit the hydroxylation of telopeptide lysines in bone collagenUlrike Schwarze, Tim Cundy, Shawna M Pyott, et al.
Pageof 10